Evidence That Selenium Binding Protein 1 Is a Tumor Suppressor in Prostate Cancer
Open Access
- 18 May 2015
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (5) , e0127295
Abstract
Selenium-Binding Protein 1 (SBP1, SELENBP1, hSP56) is a selenium-associated protein shown to be at lower levels in tumors, and its lower levels are frequently predictive of a poor clinical outcome. Distinguishing indolent from aggressive prostate cancer is a major challenge in disease management. Associations between SBP1 levels, tumor grade, and disease recurrence following prostatectomy were investigated by duplex immunofluorescence imaging using a tissue microarray containing tissue from 202 prostate cancer patients who experienced biochemical (PSA) recurrence after prostatectomy and 202 matched control patients whose cancer did not recur. Samples were matched by age, ethnicity, pathological stage and Gleason grade, and images were quantified using the Vectra multispectral imaging system. Fluorescent labels were targeted for SBP1 and cytokeratins 8/18 to restrict scoring to tumor cells, and cell-by-cell quantification of SBP1 in the nucleus and cytoplasm was performed. Nuclear SBP1 levels and the nuclear to cytoplasm ratio were inversely associated with tumor grade using linear regression analysis. Following classification of samples into quartiles based on the SBP1 levels among controls, tumors in the lowest quartile were more than twice as likely to recur compared to those in any other quartile. Inducible ectopic SBP1 expression reduced the ability of HCT-116 human tumor cells to grow in soft agar, a measure of transformation, without affecting proliferation. Cells expressing SBP1 also demonstrated a robust induction in the phosphorylation of the p53 tumor suppressor at serine 15. These data indicate that loss of SBP1 may play an independent contributing role in prostate cancer progression and its levels might be useful in distinguishing indolent from aggressive disease.Keywords
This publication has 35 references indexed in Scilit:
- Inverse association between glutathione peroxidase activity and both selenium‐binding protein 1 levels and gleason score in human prostate tissueThe Prostate, 2011
- Two-phase dynamics of p53 in the DNA damage responseProceedings of the National Academy of Sciences, 2011
- Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoproteinCarcinogenesis, 2010
- Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse XenograftsPLOS ONE, 2009
- Molecular mechanisms by which selenoproteins affect cancer risk and progressionBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Gleason Score and Lethal Prostate Cancer: Does 3 + 4 = 4 + 3?Journal of Clinical Oncology, 2009
- Anchorage-independent cell growth signature identifies tumors with metastatic potentialOncogene, 2009
- Selenium binding protein 1 in ovarian cancerInternational Journal of Cancer, 2006
- The Cooperative Prostate Cancer Tissue ResourceClinical Cancer Research, 2004
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999